Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
European Journal of Endocrinology|February 19, 2016
Development of additional pituitary hormone deficiencies in pediatric patients originally diagnosed with isolated growth hormone deficiency due to organic causesChristopher J Child, Werner F Blum, Cheri Deal, et al.
International Journal of Pediatric Endocrinology|February 15, 2013
United States multicenter study of factors predicting the persistence of GH deficiency during the transition period between childhood and adulthoodCharmian A Quigley, Anthony J Zagar, Charlie Chunhua Liu, et al.
Hormone Research in Paediatrics|June 12, 2019
Height Gain and Safety Outcomes in Growth Hormone-Treated Children with Idiopathic Short Stature: Experience from a Prospective Observational StudyChristopher J Child, Charmian A Quigley, Gordon B Cutler, et al.
The Journal of Clinical Endocrinology and Metabolism|September 14, 2006
Differences in follicle-stimulating hormone secretion between 45,X monosomy Turner syndrome and 45,X/46,XX mosaicism are evident at an early agePatricia Y Fechner, Marsha L Davenport, Rebecca L Qualy, et al.
Hormone Research in Paediatrics|May 22, 2013
Associations between pituitary imaging abnormalities and clinical and biochemical phenotypes in children with congenital growth hormone deficiency: data from an international observational studyCheri Deal, Caroline Hasselmann, Roland W Pfäffle, et al.
European Journal of Endocrinology|October 4, 2013
Development of additional pituitary hormone deficiencies in pediatric patients originally diagnosed with idiopathic isolated GH deficiencyWerner F Blum, Cheri Deal, Alan G Zimmermann, et al.
Hormone Research in Paediatrics|May 14, 2015
Radiological Features in Patients with Short Stature Homeobox-Containing (SHOX) Gene Deficiency and Turner Syndrome before and after 2 Years of GH TreatmentChristopher J Child, Gabriel Kalifa, Christine Jones, et al.
The Journal of Clinical Endocrinology and Metabolism|September 13, 2003
Effect of growth hormone (GH) treatment on bone in postpubertal GH-deficient patients: a 2-year randomized, controlled, dose-ranging studyStephen M Shalet, Elena Shavrikova, Morris Cromer, et al.
The Journal of Clinical Endocrinology and Metabolism|May 31, 2013
GH treatment to final height produces similar height gains in patients with SHOX deficiency and Turner syndrome: results of a multicenter trialWerner F Blum, Judith L Ross, Alan G Zimmermann, et al.
Mechanisms of Ageing and Development|November 16, 2004
Partial androgen insensitivity with phenotypic variation caused by androgen receptor mutations that disrupt activation function 2 and the NH(2)- and carboxyl-terminal interactionCharmian A Quigley, Jiann-an Tan, Bin He, et al.
Pageof 5